Corcept Therapeutics Insider Sold Shares Worth $2,046,351, According to a Recent SEC Filing

MT newswire2026/11/05 08:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:04 AM EST, 11/05/2026 (MT Newswires) -- Sean Maduck, Former President, Corcept Endocrinology, on November 02, 2026, sold 25,000 shares in Corcept Therapeutics (CORT) for $2,046,351. Following the Form 4 filing with the SEC, Maduck has control over a total of 129,593 common shares of the company, with 13,284 shares held directly and 116,309 controlled indirectly. This transaction was made pursuant to a 10b5-1 plan adopted by the reporting person on Dec. 8, 2025. SEC Filing: https://www.sec.gov/Archives/edgar/data/1088856/000119312526447906/xslF345X05/ownership.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Corcept Therapeutics Insider Sold Shares Worth $2,046,351, According to a Recent SEC Filing

You may also like

Crypto prices